P.133 - Development of a CRISPR/Cas9-mediated gene editing platform to restore the reading frame for 60% of Duchenne muscular dystrophy patients

A. Pyle, S. Younesi + Show 8 more

https://doi.org/10.1016/j.nmd.2016.06.153

Copy DOI

Publication Date: Sep 9, 2016

Affiliation: UCLA Health

Abstract

P.133 - Development of a CRISPR/Cas9-mediated gene editing platform to restore the reading frame for 60% of Duchenne muscular dystrophy patients

Full Text

Published version (

Free)

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author